Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Coyle

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
AIDS Research and Human Retroviruses|October 27, 2022
Demographic and Clinical Characteristics of Persons with HIV with Viral Load:Adherence Mismatch Who Are at Risk of Future ViremiaEitan Grinsteiner, Mary Morrow, Samantha Mawhinney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2018
Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus InfectionsJose R Castillo-Mancilla, Mary Morrow, Ryan P Coyle, et al.
The Journal of Infectious Diseases|April 4, 2019
Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIVMary Morrow, Samantha MaWhinney, Ryan P Coyle, et al.
Particle and Fibre Toxicology|March 21, 2024
In vitro inflammation and toxicity assessment of pre- and post-incinerated organomodified nanoclays to macrophages using high-throughput screening approachesTodd A Stueckle, Jake Jensen, Jayme P Coyle, et al.
AIDS Research and Human Retroviruses|June 18, 2019
Short Communication: Cascade of Antiretroviral Therapy Adherence in Virologically Suppressed Persons Living with HIVJose R Castillo-Mancilla, Ryan P Coyle, Stacey S Coleman, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2020
Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIVRyan P Coyle, Mary Morrow, Stacey S Coleman, et al.
Indoor Air|February 28, 2022
Reduction of exposure to simulated respiratory aerosols using ventilation, physical distancing, and universal maskingJayme P Coyle, Raymond C Derk, William G Lindsley, et al.
Chemical Research in Toxicology|March 26, 2026
Multitask Pretraining Framework for Improving Predictivity of Machine Learning Chemical Bioactivity Models for Low-Data EndpointsNoah J Wichrowski, Mary Versa Clemens-Sewall, Karun K Rao, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
An FDA-Approved Tenofovir Alafenamide-Based Antiretroviral Therapy Reduces Biological Age in Healthy Adults: First Human Proof-of-Concept for Retrotransposon-Targeted GerotherapeuticsPeter L Anderson, Alina Ps Pang, Ryan P Coyle, et al.
The Journal of Antimicrobial Chemotherapy|March 4, 2025
Cellular pharmacology of tenofovir alafenamide and emtricitabine in neutrophils and platelets in people with and without HIVVincent A Mainella, Brian Branchford, Travis Nemkov, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
AIDS Research and Human Retroviruses|October 27, 2022
Demographic and Clinical Characteristics of Persons with HIV with Viral Load:Adherence Mismatch Who Are at Risk of Future ViremiaEitan Grinsteiner, Mary Morrow, Samantha Mawhinney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2018
Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus InfectionsJose R Castillo-Mancilla, Mary Morrow, Ryan P Coyle, et al.
The Journal of Infectious Diseases|April 4, 2019
Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIVMary Morrow, Samantha MaWhinney, Ryan P Coyle, et al.
Particle and Fibre Toxicology|March 21, 2024
In vitro inflammation and toxicity assessment of pre- and post-incinerated organomodified nanoclays to macrophages using high-throughput screening approachesTodd A Stueckle, Jake Jensen, Jayme P Coyle, et al.
AIDS Research and Human Retroviruses|June 18, 2019
Short Communication: Cascade of Antiretroviral Therapy Adherence in Virologically Suppressed Persons Living with HIVJose R Castillo-Mancilla, Ryan P Coyle, Stacey S Coleman, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2020
Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIVRyan P Coyle, Mary Morrow, Stacey S Coleman, et al.
Indoor Air|February 28, 2022
Reduction of exposure to simulated respiratory aerosols using ventilation, physical distancing, and universal maskingJayme P Coyle, Raymond C Derk, William G Lindsley, et al.
Chemical Research in Toxicology|March 26, 2026
Multitask Pretraining Framework for Improving Predictivity of Machine Learning Chemical Bioactivity Models for Low-Data EndpointsNoah J Wichrowski, Mary Versa Clemens-Sewall, Karun K Rao, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
An FDA-Approved Tenofovir Alafenamide-Based Antiretroviral Therapy Reduces Biological Age in Healthy Adults: First Human Proof-of-Concept for Retrotransposon-Targeted GerotherapeuticsPeter L Anderson, Alina Ps Pang, Ryan P Coyle, et al.
The Journal of Antimicrobial Chemotherapy|March 4, 2025
Cellular pharmacology of tenofovir alafenamide and emtricitabine in neutrophils and platelets in people with and without HIVVincent A Mainella, Brian Branchford, Travis Nemkov, et al.
Pageof 20